News Focus
News Focus
Followers 744
Posts 63588
Boards Moderated 9
Alias Born 10/05/2009

Re: None

Monday, 09/19/2022 1:21:53 PM

Monday, September 19, 2022 1:21:53 PM

Post# of 3785
$RVVTF count down has started to FDA Covid19 request for EP End Point change for the EUA application/approval.

$9/share target may be conservative if approved and or there is a buy out by BP Big Pharma.

The drug #Bucillamine has been used safely for 30 years for RA, autoimmune disease and may end up being used for what is now rampant #LongHaulCovid19

The Dales Report
@TheDalesReport
$RVVTF AGM just finished. Some key takeaways:

- Revive has 450-500 patient data scrubbed/ready to present to regulators as needed
- Capital raise possible if EP swap approved
- FDA should have EP decision in 30 days
- Clinical trial sites on standby if add-on patient data needed

Check here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169985610

and Reddit and twitter for updates.

https://www.reddit.com/r/RVVTF/comments/xfn7va/revive_therapeutics_provides_update_on_the/

Also Covid19 and virus DD central on discord is here

https://discord.gg/s8VTSXVC

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today